Literature DB >> 21774076

ABCG2 is required to control the sonic hedgehog pathway in side population cells with stem-like properties.

Jana Balbuena1, Gisela Pachon, Guillermo Lopez-Torrents, Josep M Aran, Javier S Castresana, Jordi Petriz.   

Abstract

The Sonic Hedgehog (Hh) pathway has been implicated in the maintenance of stem or progenitor cells in many adult tissues. Importantly, abnormal Hh pathway activation is also associated with initiation of neoplasia, but its role in tumor growth is still unclear. Here, we demonstrate that cyclopamine, a plant-derived alkaloid product used to inhibit the Hh signaling pathway, reduces the Side Population (SP) obtained by Hoechst 33342 (Ho342) dye measurements. In addition, cyclopamine is able to modulate, along with oxysterols and other products, the ABCG2 transporter by increasing Ho342 and mitoxantrone uptake. Therefore, if the SP is solely measured as a Ho342 dye extruding fraction, this may be significantly modulated by the inhibition of ABCG2 transport fraction, independently from the action of cyclopamine on the Hh pathway. Our results indicate that ABCG2 may act in the upstream regulation of the Hh signaling pathway to protect the stemness of the SP compartment, giving support to the cancer stem cell hypothesis and suggesting that ABCG2 is not only critical for increased resistance to anticancer agents.
Copyright © 2011 International Society for Advancement of Cytometry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21774076     DOI: 10.1002/cyto.a.21103

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  10 in total

1.  Axitinib targeted cancer stemlike cells to enhance efficacy of chemotherapeutic drugs via inhibiting the drug transport function of ABCG2.

Authors:  Fang Wang; Yan-jun Mi; Xing-Gui Chen; Xing-ping Wu; Zhenguo Liu; Shu-peng Chen; Yong-ju Liang; Chao Cheng; Kenneth Kin Wah To; Li-wu Fu
Journal:  Mol Med       Date:  2012-07-18       Impact factor: 6.354

2.  Mithramycin represses basal and cigarette smoke-induced expression of ABCG2 and inhibits stem cell signaling in lung and esophageal cancer cells.

Authors:  Mary Zhang; Aarti Mathur; Yuwei Zhang; Sichuan Xi; Scott Atay; Julie A Hong; Nicole Datrice; Trevor Upham; Clinton D Kemp; R Taylor Ripley; Gordon Wiegand; Itzak Avital; Patricia Fetsch; Haresh Mani; Daniel Zlott; Robert Robey; Susan E Bates; Xinmin Li; Mahadev Rao; David S Schrump
Journal:  Cancer Res       Date:  2012-07-02       Impact factor: 12.701

3.  Isocyclopamine, a novel synthetic derivative of cyclopamine, reverts doxorubicin resistance in MCF-7/ADR cells by increasing intracellular doxorubicin accumulation and downregulating breast cancer stem-like cells.

Authors:  Ming Liu; Weiyi Zhang; Wei Tang; Yanjuan Wang; Xingzeng Zhao; Xiangyun Wang; Xin Qi; Jing Li
Journal:  Tumour Biol       Date:  2015-09-02

4.  The side population in human lung cancer cell line NCI-H460 is enriched in stem-like cancer cells.

Authors:  Yang Shi; Xuelian Fu; Yong Hua; Yang Han; Ying Lu; Junchen Wang
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

5.  Inhibition of CK2α down-regulates Hedgehog/Gli signaling leading to a reduction of a stem-like side population in human lung cancer cells.

Authors:  Shulin Zhang; Yucheng Wang; Jian-Hua Mao; David Hsieh; Il-Jin Kim; Li-Min Hu; Zhidong Xu; Hao Long; David M Jablons; Liang You
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

6.  Kinetic Modeling of ABCG2 Transporter Heterogeneity: A Quantitative, Single-Cell Analysis of the Side Population Assay.

Authors:  Adam F Prasanphanich; Douglas E White; Margaret A Gran; Melissa L Kemp
Journal:  PLoS Comput Biol       Date:  2016-11-16       Impact factor: 4.475

7.  Xanthohumol, a Prenylated Chalcone from Hops, Inhibits the Viability and Stemness of Doxorubicin-Resistant MCF-7/ADR Cells.

Authors:  Ming Liu; Hua Yin; Xiaokun Qian; Jianjun Dong; Zhonghua Qian; Jinlai Miao
Journal:  Molecules       Date:  2016-12-28       Impact factor: 4.411

8.  An overview of therapeutic approaches to brain tumor stem cells.

Authors:  Alireza Khoshnevisan
Journal:  Med J Islam Repub Iran       Date:  2012-02

9.  ABCG2 regulates self-renewal and stem cell marker expression but not tumorigenicity or radiation resistance of glioma cells.

Authors:  Boyoung Wee; Alexander Pietras; Tatsuya Ozawa; Elena Bazzoli; Ondrej Podlaha; Christophe Antczak; Bengt Westermark; Sven Nelander; Lene Uhrbom; Karin Forsberg-Nilsson; Hakim Djaballah; Franziska Michor; Eric C Holland
Journal:  Sci Rep       Date:  2016-07-26       Impact factor: 4.379

10.  Targeting oral cancer stemness and chemoresistance by isoliquiritigenin-mediated GRP78 regulation.

Authors:  Fang-Wei Hu; Cheng-Chia Yu; Pei-Ling Hsieh; Yi-Wen Liao; Ming-Yi Lu; Pei-Ming Chu
Journal:  Oncotarget       Date:  2017-09-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.